These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27774775)

  • 1. Galactosylated Lipidoid Nanoparticles for Delivery of Small Interfering RNA to Inhibit Hepatitis C Viral Replication In Vivo.
    Park HJ; Jeon EJ; Lee JS; Hong SH; Cho AN; Lee J; Moon JS; Jung KE; Oh JW; Lee H; Cho SW
    Adv Healthc Mater; 2016 Nov; 5(22):2931-2941. PubMed ID: 27774775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hepatitis C virus in mouse models by lipidoid nanoparticle-mediated systemic delivery of siRNA against PRK2.
    Moon JS; Lee SH; Han SH; Kim EJ; Cho H; Lee W; Kim MK; Kim TE; Park HJ; Rhee JK; Kim SJ; Cho SW; Han SH; Oh JW
    Nanomedicine; 2016 Aug; 12(6):1489-98. PubMed ID: 27013134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of hepatitis C virus replication by protein kinase C-related kinase 2 inhibitors that block phosphorylation of viral RNA polymerase.
    Kim SJ; Kim JH; Sun JM; Kim MG; Oh JW
    J Viral Hepat; 2009 Oct; 16(10):697-704. PubMed ID: 19243496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target delivery of small interfering RNAs with vitamin E-coupled nanoparticles for treating hepatitis C.
    Duan L; Yan Y; Liu J; Wang B; Li P; Hu Q; Chen W
    Sci Rep; 2016 Apr; 6():24867. PubMed ID: 27113197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hepatitis C virus replication by intracellular delivery of multiple siRNAs by nanosomes.
    Chandra PK; Kundu AK; Hazari S; Chandra S; Bao L; Ooms T; Morris GF; Wu T; Mandal TK; Dash S
    Mol Ther; 2012 Sep; 20(9):1724-36. PubMed ID: 22617108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of hepatitis C virus-specific short hairpin RNA in mouse liver using Sendai virosomes.
    Subramanian N; Mani P; Roy S; Gnanasundram SV; Sarkar DP; Das S
    J Gen Virol; 2009 Aug; 90(Pt 8):1812-1819. PubMed ID: 19297606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
    Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
    J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy.
    Mizui T; Yamashina S; Tanida I; Takei Y; Ueno T; Sakamoto N; Ikejima K; Kitamura T; Enomoto N; Sakai T; Kominami E; Watanabe S
    J Gastroenterol; 2010 Feb; 45(2):195-203. PubMed ID: 19760134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
    Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
    Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Target delivery of small interfering RNAs with vitamin E- loaded lipid nanoparticles in inhibition of hepatitis C virus core protein expression in mouse model].
    Ye YY; Chen H; Yan Y; Chen L; Huang WX
    Zhonghua Gan Zang Bing Za Zhi; 2018 May; 26(5):382-387. PubMed ID: 29996208
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNA.
    Sakamoto N; Tanabe Y; Yokota T; Satoh K; Sekine-Osajima Y; Nakagawa M; Itsui Y; Tasaka M; Sakurai Y; Cheng-Hsin C; Yano M; Ohkoshi S; Aoyagi Y; Maekawa S; Enomoto N; Kohara M; Watanabe M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1437-47. PubMed ID: 17683479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice.
    Nakagawa S; Umehara T; Matsuda C; Kuge S; Sudoh M; Kohara M
    Biochem Biophys Res Commun; 2007 Feb; 353(4):882-8. PubMed ID: 17196931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot.
    Moon JS; Lee SH; Kim EJ; Cho H; Lee W; Kim GW; Park HJ; Cho SW; Lee C; Oh JW
    PLoS One; 2016; 11(1):e0146710. PubMed ID: 26751678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of hepatitis C virus replication by a non-viral vector based on solid lipid nanoparticles containing a shRNA targeted to the internal ribosome entry site (IRES).
    Torrecilla J; Del Pozo-Rodríguez A; Solinís MÁ; Apaolaza PS; Berzal-Herranz B; Romero-López C; Berzal-Herranz A; Rodríguez-Gascón A
    Colloids Surf B Biointerfaces; 2016 Oct; 146():808-17. PubMed ID: 27451369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of DHCR24 expression by hepatitis C virus infection facilitates viral replication in hepatocytes.
    Takano T; Tsukiyama-Kohara K; Hayashi M; Hirata Y; Satoh M; Tokunaga Y; Tateno C; Hayashi Y; Hishima T; Funata N; Sudoh M; Kohara M
    J Hepatol; 2011 Sep; 55(3):512-521. PubMed ID: 21184787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi).
    Pan Q; Ramakrishnaiah V; Henry S; Fouraschen S; de Ruiter PE; Kwekkeboom J; Tilanus HW; Janssen HL; van der Laan LJ
    Gut; 2012 Sep; 61(9):1330-9. PubMed ID: 22198713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hepatitis C virus genotype 4 replication using siRNA targeted to the viral core region and the CD81 cellular receptor.
    Aljowaie RM; Almajhdi FN; Ali HH; El-Wetidy MS; Shier MK
    Cell Stress Chaperones; 2020 Mar; 25(2):345-355. PubMed ID: 32060691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.
    Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C
    Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model.
    Kim M; Shin D; Kim SI; Park M
    Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of siRNA against hepatitis C virus by apolipoprotein A-I-bound cationic liposomes.
    Kim SI; Shin D; Lee H; Ahn BY; Yoon Y; Kim M
    J Hepatol; 2009 Mar; 50(3):479-88. PubMed ID: 19155084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.